Having shown that many STAG2 mutations do not abrogate the ability of STAG2 to interact with cohesin (Figs 2 and 3), we next hypothesized that tumor-derived mutations in STAG2 might instead lead to generalized abnormalities in the subunit composition of the cohesin complex itself. Here, STAG2 is linked to neoplasm.